12/23/22 4:05 PMAMEX : OGEN low floatOragenics, Inc. Discloses One-for-Sixty Reverse Stock SplitOragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, today announced that its Board of Directors on December 22, 2022 approved a 1- for-60 reverse stock split of the Company’ s issued and outstanding shares of common stock, par value $0.001 per share, accompanied by a corresponding decrease in the Company’ s...RHEA-AIneutral
12/22/22 7:30 AMAMEX : OGEN covid-19low floatOragenics Reports Favorable Toxicology Results for its COVID-19 Intranasal Vaccine CandidateOragenics, Inc., a biotechnology company dedicated to fighting infectious diseases including COVID-19, today announced results indicating no toxicity signals or adverse events from its Good Laboratory Practices toxicology study in rabbits evaluating the safety and immunogenicity of its NT-CoV2-1 intranasal vaccine candidate.RHEA-AIneutral
12/20/22 4:36 PMAMEX : OGEN low floatOragenics, Inc. Receives NYSE American NoticeOragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, today announced that it received a Notice on December 19, 2022 from the NYSE American LLC stating that the Company is not in compliance with the continued listing standards as set forth in Section 1003 of the NYSE American Company Guide. The Company’ s receipt of...RHEA-AIneutral
12/19/22 4:34 PMAMEX : OGEN low floatOragenics, Inc. Announces New ChairOragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, today announced that on December 16, 2022 the Board of Directors appointed Charles Pope as its Chairman of the Board of Directors succeeding Dr. Dr. Telling stated:“ It has been an honor and privilege to serve as Chairman of Oragenics for over a decade and I look...RHEA-AIvery positive
10/24/22 4:01 PMAMEX : OGEN conferenceslow floatOragenics to Participate in the 2022 BioFlorida Annual ConferenceOragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, announces its participation in the 2022 BioFlorida Annual Conference, being held November 2-4 in Miami. Oragenics, Inc. is a development-stage company dedicated to fighting infectious diseases, including those caused by coronaviruses and...RHEA-AIneutral
09/30/22 7:30 AMAMEX : OGEN low floatOragenics Issues Letter to ShareholdersOragenics, Inc., a biotech company dedicated to fighting infectious diseases including coronaviruses, today issued the following letter to shareholders from its President and Chief Executive Officer, Kim Murphy. As most of you know, in late June I took over the day-to-day leadership of Oragenics from Fred Telling, and we are fortunate that Fred remains a...RHEA-AIneutral
08/24/22 7:00 AMAMEX : OGEN covid-19low floatOragenics Announces Favorable Preliminary Toxicology Data for Intranasal COVID-19 Vaccine CandidateOragenics, Inc., a biotech company dedicated to fighting infectious diseases including COVID-19, today announced favorable preliminary results from its ongoing Good Laboratory Practice toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine candidate in rabbits. Oragenics previously published positive...RHEA-AIneutral
06/23/22 4:30 PMAMEX, Nasdaq : OGEN, BWV, CRXT managementlow floatOragenics Appoints Seasoned Vaccine Executive Kimberly Murphy as President and Chief Executive OfficerOragenics, Inc., a biotech company dedicated to fighting infectious diseases including coronaviruses, announces the appointment of Ms. Ms. Murphy brings more than 25 years of vaccine industry experience at leading pharmaceutical companies including serving as a key leader in the successful US and Global launch of Merck’ s HPV/Gardasil Franchise.RHEA-AIvery positive
06/14/22 7:30 AMAMEX : OGEN covid-19low floatOragenics Announces Publication of Positive Data for its NT-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific ReportsOragenics, Inc., a biotech company dedicated to fighting infectious diseases including coronavirus, announces the publication of an article co-authored by Oragenics and collaborators at Inspirevax and the National Research Council of Canada Human Health Therapeutics Research Centre in Scientific Reports, a Nature journal. These published data, and our...RHEA-AIneutral
05/17/22 7:30 AMAMEX : OGEN low floatOragenics Issues Letter to ShareholdersOragenics, Inc. today issued the following letter to shareholders from its Executive Chairman, Frederick W. Telling, Ph.D.:. I thank you for your continued support of Oragenics and our vision, and am delighted to report on our recent progress. In previous letters I affirmed the strategic direction Oragenics is taking and discussed our commitment to the speedy yet...RHEA-AIneutral